| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Sidney H. Kennedy | |
| Shane J. McInerney | |||
| P2860 | cites work | Strategies to Reduce Misdiagnosis of Bipolar Depression | Q22241851 |
| Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication | Q22253034 | ||
| Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial | Q24629398 | ||
| Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up | Q28182929 | ||
| Pramipexole for bipolar II depression: a placebo-controlled proof of concept study | Q28268655 | ||
| Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients | Q48886105 | ||
| Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. | Q50929769 | ||
| Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. | Q51053741 | ||
| The relationship between use of antidepressants and resource utilization among patients with manic or mixed bipolar disorder episodes: findings from a managed care setting. | Q51360835 | ||
| Differences in outcome of DSM-IV bipolar I and II disorders. | Q51892026 | ||
| Melancholia agitata and mixed depression. | Q51907245 | ||
| Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. | Q51948101 | ||
| Mixed depressive syndrome | Q68146980 | ||
| A double-blind study of tranylcypromine treatment of major anergic depression | Q70255159 | ||
| Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness | Q70534269 | ||
| Fluvoxamine and chlorimipramine in endogenous depression | Q72767715 | ||
| Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression | Q73317622 | ||
| Bipolar depression: an underestimated treatment challenge | Q73600638 | ||
| Venlafaxine monotherapy in women with bipolar II and unipolar major depression | Q73897688 | ||
| Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania | Q74176274 | ||
| Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant | Q74283261 | ||
| Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders | Q79535158 | ||
| Treatment of bipolar disorder | Q82247677 | ||
| Long-term worsening of bipolar disorder related with frequency of antidepressant exposure | Q84642298 | ||
| Effectiveness of adjunctive antidepressant treatment for bipolar depression | Q28295408 | ||
| The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders | Q30583384 | ||
| Quality of life in patients with bipolar I depression: data from 920 patients | Q30961525 | ||
| Historical perspectives and natural history of bipolar disorder | Q33920209 | ||
| Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression | Q33949128 | ||
| Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study | Q33959019 | ||
| Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). | Q34000973 | ||
| A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). | Q34096127 | ||
| Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression | Q34275783 | ||
| Antidepressants for bipolar depression: a systematic review of randomized, controlled trials | Q34344394 | ||
| Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice | Q34448125 | ||
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder | Q34649187 | ||
| A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression | Q34658735 | ||
| Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials | Q34749757 | ||
| Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006 | Q35211109 | ||
| Antidepressants in bipolar disorder: the case for caution | Q35592492 | ||
| Pharmacotherapy for the treatment of acute bipolar II depression: current evidence | Q35954969 | ||
| Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder | Q36732869 | ||
| Antidepressants in the treatment of bipolar disorder: decoding contradictory evidence and opinion | Q37196569 | ||
| Treatment options for bipolar depression: a systematic review of randomized, controlled trials | Q37784981 | ||
| Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis | Q37804942 | ||
| A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). | Q38376026 | ||
| Antidepressant-induced mania and cycle acceleration: a controversy revisited | Q40977115 | ||
| Bipolar depression: treatment options. | Q41588618 | ||
| Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial | Q42655788 | ||
| Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. | Q43867164 | ||
| Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers | Q43931805 | ||
| A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. | Q44044001 | ||
| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. | Q44142664 | ||
| Screening for bipolar disorder in the community | Q44318544 | ||
| Suicidal risk factors in bipolar I and II disorder patients | Q44926849 | ||
| Demographic and clinical characteristics of individuals in a bipolar disorder case registry | Q45027844 | ||
| The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 | ||
| Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction | Q46516221 | ||
| A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression | Q46580881 | ||
| Self-assessment and characteristics of mixed depression in the French national EPIDEP study. | Q47314354 | ||
| Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study | Q48146535 | ||
| Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study | Q48407645 | ||
| Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients | Q48431874 | ||
| Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders | Q48586103 | ||
| Mania and depression. Mixed, not stirred. | Q48883016 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar depression | Q56014658 |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | The primary care companion for CNS disorders | Q26853834 |
| P1476 | title | Review of evidence for use of antidepressants in bipolar depression | |
| P478 | volume | 16 |
| Q53566128 | A Qualitative Exploration of Clinician Views and Experiences of Treatment Decision-Making in Bipolar II Disorder. |
| Q30357298 | Animal models of bipolar mania: The past, present and future. |
| Q34676317 | Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology |
| Q37672555 | Major depression in primary care: making the diagnosis |
| Q56395428 | Patterns and predictors of off-label prescription of psychiatric drugs |
| Q26751363 | Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review |
Search more.